Pfizer starts trials for omicron-specific booster l GMA

The pharmaceutical company announced the beginning of its trials, with more than 1,400 patients set to receive one or more doses of the variant-based vaccine.

Read more: https://abcn.ws/33Q3Uqb

#ABCNews #Pfizer #Booster #Omicron

source